New Nordic Healthbrands AB (publ)

DB:N9X Stock Report

Market Cap: €8.1m

New Nordic Healthbrands Past Earnings Performance

Past criteria checks 0/6

New Nordic Healthbrands's earnings have been declining at an average annual rate of -62.2%, while the Personal Products industry saw earnings growing at 2.9% annually. Revenues have been growing at an average rate of 3.9% per year.

Key information

-62.2%

Earnings growth rate

-62.2%

EPS growth rate

Personal Products Industry Growth8.7%
Revenue growth rate3.9%
Return on equity-15.7%
Net Margin-2.8%
Next Earnings Update28 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How New Nordic Healthbrands makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:N9X Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24543-153620
30 Jun 24549-123630
31 Mar 24538-103580
31 Dec 23534-63500
30 Sep 23503-43280
30 Jun 2349013150
31 Mar 23490-33180
31 Dec 22488-33220
30 Sep 22497-43280
30 Jun 22500-43340
31 Mar 22510123290
31 Dec 21515213210
30 Sep 21512283120
30 Jun 21502283020
31 Mar 21466232830
31 Dec 20450182840
30 Sep 20447202800
30 Jun 20449252790
31 Mar 20461272880
31 Dec 19453282790
30 Sep 19436312680
30 Jun 19430302640
31 Mar 19409282530
31 Dec 18394272430
30 Sep 18383262320
30 Jun 18358222170
31 Mar 18352232070
31 Dec 17345202040
30 Sep 17329141990
30 Jun 17325121970
31 Mar 17312101910
31 Dec 16306101850
30 Sep 16310121860
30 Jun 16300101800
31 Mar 16300111790
31 Dec 15298111780
30 Sep 15294121730
30 Jun 15285131660
31 Mar 15284131630
31 Dec 14272121550
30 Sep 14261101510
30 Jun 1425471480
31 Mar 1423871420
31 Dec 1322861370

Quality Earnings: N9X is currently unprofitable.

Growing Profit Margin: N9X is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: N9X is unprofitable, and losses have increased over the past 5 years at a rate of 62.2% per year.

Accelerating Growth: Unable to compare N9X's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: N9X is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (10.8%).


Return on Equity

High ROE: N9X has a negative Return on Equity (-15.72%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 08:46
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

New Nordic Healthbrands AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution